Latest Breaking News On - சுஷிலா கட்டாரியா - Page 1 : comparemela.com
Fact Check: Is the Regeneron Treatment the Same As Getting a COVID Vaccine?
newsweek.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsweek.com Daily Mail and Mail on Sunday newspapers.
TheHealthSite com Summit Season 2 Concludes With a Grand Success
adgully.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from adgully.com Daily Mail and Mail on Sunday newspapers.
Honeypreet Will Remain As Ram Rahim s Attendant Till June 15, Get Card Made | गुरुग्रामच्या मेदांता रुग्णालयात करणार बाबांची देखरेख, 15 जूनपर्यंतचे बनवले अटेंडेंट कार्ड
bhaskar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bhaskar.com Daily Mail and Mail on Sunday newspapers.
Doctors call monoclonal antibody cocktail ‘first Covid treatment’
SECTIONS
Share
Synopsis
The antibody cocktail is a combination of Casirivimab and Imdevimab, which are laboratory made monoclonal antibodies. The cocktail works just like antibodies produced in the human body in response to any viral infection.
Getty Images
The initial use of monoclonal antibody cocktail, the combination of drugs used on former US President Donald Trump and given emergency use approval in India in early May, has given encouraging results, with doctors involved touting it as the “first real treatment for Covid-19”.
Eight-four-year-old Mohabbat Singh, a resident of Haryana, was the first patient in India to be administered the antibody drug cocktail at Medanta Medicity, Gurugram, on May 25. The doctor treating him, Sushila Kataria, told ET, “the patient has tested negative. We have administered the drug cocktail to 15 patients so far. All are fine. This is the first real treatment for Co
NEW DELHI: Mohabbat Singh, 84, from Haryana has become the first person in India to be administered the “famous” Covid drug cocktail given to former US president Donald Trump. Singh, who has been under treatment for the past five days, was given the drug over 30-minute intravenous supply on Tuesday at Medanta, Gurugram.
The drug, Regeneron, is touted as a breakthrough treatment for certain patients as it shortens symptom duration and reduces viral load by fast acting antibodies.
The first batch of the Roche drug with two antibodies Casirivimab and Imdevimab reached India on Monday. “This drug is different from convalescent plasma and entirely different from repurposed drugs like Remdesivir or Tocilizumab. Studies show that 80% of patients who took this drug didn’t need hospitalisation, and it also reduced death rate in addition to shortening the duration of symptoms,” Dr Naresh Trehan, director, Medanta, told TOI.